Drug Trial Radar · NCT00002032
Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial
Last checked: Nov 19, 2026Latest source record: Jun 24, 2005 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
750
Actual
Start
Not stated
Primary completion
Not stated
Sponsor
- Lead sponsor
- PharmaciaPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Aug 31, 2001
Design
- Study type
- Interventional
- Phase
- Not applicable
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objectives of this trial are: To compare the safety of oral rifabutin versus placebo in the treatment of Mycobacterium avium complex (MAC) bacteremia in AIDS patients with CD4 counts less than or equal to 200 cells/mm3. To investigate the incidence of MAC in these patients. A secondary objective is to compare clinical response, quality of life (Karnofsky), and survival between these two groups.
Conditions
- Mycobacterium Avium-intracellulare Infection
- HIV Infections
Interventions
RifabutinDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
33 sites in 1 country. Site status is shown where the registry gives one.
Ctr for Special Immunology
Irvine, California
Olive View Med Ctr
Sylmar, California
Denver Public Health Dept
Denver, Colorado
Veterans Administration Med Ctr
Washington D.C., District of Columbia
Ctr for Special Immunology
Fort Lauderdale, Florida
TheraFirst Med Ctrs Inc
Fort Lauderdale, Florida
Mem Hosp Hollywood
Hollywood, Florida
VP Med Services / HHCS Research Institute Inc
Orlando, Florida
AIDS Research Consortium of Atlanta
Atlanta, Georgia
Grady Memorial Hosp / Hughs Spalding Med Ctr
Atlanta, Georgia
Dr Winkler Weinberg
Roswell, Georgia
Johns Hopkins School of Medicine
Baltimore, Maryland
CRI of New England
Brookline, Massachusetts
Univ of Missouri at Kansas City School of Medicine
Kansas City, Missouri
Research Med Ctr
Kansas City, Missouri
Brooklyn Veterans Administration
Brooklyn, New York
Maimonides Med Ctr
Brooklyn, New York
Nassau County Med Ctr
East Meadow, New York
Long Island Jewish Med Ctr
New Hyde Park, New York
Community Research Initiative
New York, New York
Chelsea Village Med Ctr
New York, New York
Mem Sloan - Kettering Cancer Ctr
New York, New York
Univ Hosp of Cleveland / Case Western Reserve Univ
Cleveland, Ohio
Ohio State Univ Med Ctr
Columbus, Ohio
Central Texas Med Foundation
Austin, Texas
Nelson Tebedo Community Clinic
Dallas, Texas
Univ of Texas Southwestern Med Ctr of Dallas
Dallas, Texas
Texas Tech Health Sciences Ctr
El Paso, Texas
Baylor College of Medicine
Houston, Texas
Houston Clinical Research Network
Houston, Texas
Univ TX San Antonio Health Science Ctr
San Antonio, Texas
Scott and White Hosp
Temple, Texas
Dr Scott Lea
Waco, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.